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The present paper examines the nature and function of brain-derived neurotrophic factor (BDNF) in the hippocampal formation
and the consequences of changes in its expression. The paper focuses on literature describing the role of BDNF in hippocampal
development and neuroplasticity. BDNF expression is highly sensitive to developmental and environmental factors, and increased
BDNF signaling enhances neurogenesis, neurite sprouting, electrophysiological activity, and other processes reﬂective of a general
enhancement of hippocampal function. Such increases in activity may mediate beneﬁcial eﬀects such as enhanced learning and
memory. However, the increased activity also comes at a cost: BDNF plasticity renders the hippocampus more vulnerable to
hyperexcitability and/or excitotoxic damage. Exercise dramatically increases hippocampal BDNF levels and produces behavioral
eﬀects consistent with this phenomenon. In analyzing the literature regarding exercise-induced regulation of BDNF, this paper
provides a theoretical model for how the potentially deleterious consequences of BDNF plasticity may be modulated by other
endogenous factors. The peptide galanin may play such a role by regulating hippocampal excitability.
1. Brain-DerivedNeurotrophicFactorOverview
Brain-derived neurotrophic factor (BDNF) is a member of
the neurotrophin family, a group of structurally related
polypeptide growth factors. The family also includes nerve
growth factor (NGF), neurotrophin-3 (NT-3), and neuro-
trophin-4 (NT-4/5) [1]. Other neurotrophins have also been
identiﬁed, NT-6 and NT-7; however, these likely do not exist
in mammals [2–4]. Neurotrophins activate one or more of
the high-aﬃnity tropomyosin-receptor kinase (Trk) receptor
family [1, 5, 6], as well as the low-aﬃnity p75 neurotrophin
receptor (p75NTR) [7].
Neurotrophins direct growth and diﬀerentiation in the
developing nervous system [1, 3, 6, 8]. Levels of the diﬀerent
neurotrophins relate in a predictable pattern to stages of
embryonic development. Infusion of BDNF into the adult
brain promotes neurogenesis [9, 10], and dendritic spine re-
organization in the rat hippocampal formation [11]. BDNF
gene transfection triggers dendritic and axonal branching in
dentate gyrus (DG) granule cell cultures [12] while mice
withatargetedgenedeletionshowsubstantialimpairmentin
normal cerebellar development, among other developmental
and behavioral deﬁcits [13].
Trk receptors precipitate the activation of many signaling
cascades, including phospholipase C (PLC), phosphoinosi-
tide 3-kinase (PI3K), and Ras [14, 15], which are involved in
diﬀerent aspects of neuronal survival [16] and neurite out-
growth [17–19]. The p75NTR is implicated in both pro- and
antitrophic processes, such as neurite outgrowth [20]a n d
apoptosis [14, 21, 22].
BDNF regulates synaptic transmission and activity-
dependentplasticity[23,24]andpromoteslong-termpoten-
tiation (LTP)[25]. Its eﬀects on LTP occur through both pre-
andpostsynapticmechanisms[26].BDNFexertspresynaptic
eﬀects in a retrograde or paracrine fashion [27, 28]a n d
postsynaptic eﬀects by modulating NMDA receptor subunit
expression [29]. Experimental reductions in BDNR or TrkB
activity signiﬁcantly impair LTP [25, 30, 31].
Previous research has demonstrated that exercise in-
creases hippocampal BDNF mRNA [32, 33]a n dp r o t e i n2 International Journal of Peptides
[34, 35]. The eﬀect of exercise to augment BDNF activ-
ity depends on cAMP-response-element binding protein
(CREB) activation, as CREB suppression mitigates this eﬀect
[36]. Increases in hippocampal BDNF mRNA have been de-
tected after a period of running as short as 6 hours [37], to
as long as two months [38], signifying a sensitive yet sus-
tainable eﬀect. Physical activity leads to greater activation
of cellular signaling pathways associated with survival [39]
and neurogenesis [40], and can enhance hippocampal LTP
induction [32], all of which strongly implicate BDNF in their
eﬀects.
This review will describe how BDNF and neurotrophins
are involved in nervous system development, the signal
transduction mechanisms associated with neurotrophin ac-
tivity, and the modulating role BDNF plays in synaptic
plasticity and LTP. The inﬂuence of exercise on BDNF ac-
tivity, especially in the hippocampus, and the relationship
between BDNF and excitotoxicity will also be examined.
2. Signal Transduction
BDNF and NT-4/5 bind to TrkB receptors [41, 42], as does
NT-3 to a lesser extent. NGF binds to TrkA receptors, and
NT-3 binds to TrkC receptors [5]. When a ligand binds to
aT r kr e c e p t o r( s e eFigure 1), the receptor dimerizes and
autophosphorylates tyrosine residues to yield docking sites
for the src homology 2 domain-containing adapter protein
(Shc) [43] and phospholipase C-γ (PLC-γ), which are cou-
pledtointracellularsignalingcascadessuchasRas[44],PI3K
[45, 46], and, as mentioned, PLC-γ [14, 15, 47, 48].
Shc regulates protein interactions by binding, with a
high-aﬃnity, tyrosine-phosphorylated sites, and in this way
regulates intracellular signaling such as Ras [43]. Once Shc is
docked with the receptor and bound to the adapter protein
Grb2, Ras promotes activation of the mitogen-activated
protein kinase (MAPK)/extracellular signal regulated kinase
(ERK) cascade, as well as the PI3K cascade [3, 15]. Ras is
linked to Grb2 by the guanine nucleotide releasing factor
SOS [49]. MAPK/ERK is essential for neurogenesis [50]a n d
promotes survival by two ways, by induction of prosurvival
genes and inhibition of proapoptotic proteins [51]. Ras also
suppressesapoptosisviaPI3K[16];PI3KactivatesAkt,which
sequesters pro-apoptotic proteins in the cytoplasm away
from their transcriptional targets [52].
The PI3K cascade can be activated two ways by Trk re-
ceptors, through Ras as well as through adapter proteins
Shc, Grb2, and Grb2-associated binder-1 (Gab1) [15, 45].
In some neurons, BDNF phosphorylates the insulin receptor
substrate, which can activate PI3K as well [46]. Vaillant and
colleagues [16] demonstrated that inhibition of any portion
of the Ras-PI3K-Akt pathway signiﬁcantly reduced survival
of sympathetic neurons in culture in the presence of NGF.
The adapter proteins Shc and PLC-γ are phosphorylated
once they dock with the Trk receptor [3, 14, 47]. Once
activated, PLC-γ then catalyzes the breakdown of lipids
to inositol 1,4,5 triphosphate (IP3), which promotes the
release of calcium from intracellular stores, and a subsequent
increase in intracellular calcium concentration and diacyl-
glycerol (DAG) occurs [48]. DAG regulates protein kinase C
(PKC-δ), which may be required for the MAPK/ERK signal
[17], and both DAG and MAPK/ERK have been implicated
in neurite outgrowth [18, 19]. Interestingly, LTP is inhibited
when PLC-γ signaling is blocked [26], which may be related
to reduced IP3 formation and subsequent reduction in
intracellular calcium release.
The other neurotrophin-responsive receptor, the
p75NTR, can bind to each factor and regulate the Trk recep-
tor aﬃnity for its ligand [53]. The Trk receptors and the
p75NTR are often present in close proximity on the cellular
membrane [54]. While TrkB responds to NT-3, NT-4/5,
and BDNF [5], the receptor selectively binds only BDNF
when colocalized with p75NTR [54]. The largely presynaptic
p75NTR [55] serves dual roles in that it modulates Trk re-
ceptor binding and is involved in prolonged Ras-mediated
activation of ERK and neurite outgrowth [20], though
p75NTR-induced neurite outgrowth ceases after prolonged
p75NTR activation [20]. The p75NTR also activates c-jun
N-terminal kinase (JNK) [56]a n dc a u s e sa p o p t o s i si na
variety of neurons [14, 21, 22].
Although all Trk receptors are assumed to behave in
much the same fashion, diﬀerences do exist [53]. Kaplan and
Miller [14] demonstrated, using TrkB receptors with mu-
t a t i o n sa td i ﬀerent binding sites, that TrkB receptors use
both PI3K and MAPK cascades for cell survival while TrkA
receptors depend mainly on PI3K. This demonstrates some
comparative ﬂexibility for TrkB receptors with regard to pro-
survival function. Importantly, two truncated forms of TrkB
receptors exist that lack tyrosine kinase function [57]a n d
bind BDNF to negatively modulate TrkB activity [58].
3.Development
Given that BDNF-associated signaling modulates neuron
survival and apoptosis, much attention has been focused on
the role of BDNF (and other neurotrophins) in develop-
ment. Indeed, the critical involvement of Trk receptors in
neuronal survival [16, 50–52], neurogenesis [10], and neu-
rite outgrowth [12, 18, 19] implicates BDNF in develop-
mental processes. Throughout development, neurotrophins
inﬂuence and guide neuronal diﬀerentiation in the central
nervous system (CNS) [6, 8] and peripheral nervous system
(PNS) [1, 3]. Barnab´ e-Heider and Miller [50] demonstrated
that cortical progenitor cells express BDNF and NT-3 and
their associated TrkB and TrkC receptors, and that these
neurotrophinswereessentialtothesurvivaloftheprogenitor
cells.
BDNF mRNA expression is lowest in the brains of early
rat embryos and increases into adulthood [59]. It demon-
strates a reciprocal relationship with NT-3 mRNA, which
is at the highest levels in early embryos. Maisonpierre and
colleagues [59] characterized distribution of BDNF, NT-3,
and NGF mRNA during rat development and found that the
amount of all three dramatically increased between embry-
onic days 11 and 12, with transcripts widely distributed by
embryonic day 13. This timing corresponds directly to theInternational Journal of Peptides 3
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Figure 1: TrkB transduction mechanisms. Aspects adapted from [1, 15].
onset of robust neurogenesis in the peripheral and central
nervous systems [60, 61]. BDNF transcript levels continued
to increase into adulthood, especially in the hippocampus
[59].
Katoh-Semba et al. [62] examined BDNF protein con-
centration during postnatal development in rats and found
that levels in the septum, cerebellum, and hippocampus in-
creasedovertimeandthenstabilized(althoughhippocampal
protein levels took much longer to plateau) while hypotha-
lamic BDNF protein levels increased for a period following
birth and then decreased. Kim et al. [63] further inves-
tigated BDNF-immunoreactivity (IR) in the rat forebrain
and upper brainstem during postnatal development. The
investigators deﬁned three groups of BDNF cells: those that
are detected early, increase in number, and remain stable
during adulthood (e.g., piriform cortex, cingulate gyrus),
those that increase with age then decrease in adulthood
(e.g., basolateral nucleus of the amygdala), and those that
appear brieﬂy before dramatic reductions in adulthood (e.g.,
substantia nigra, various hypothalamic nuclei).
In the hippocampus, BDNF-IR cells appeared in the
pyramidal layer of CA2 and CA3 early on (postnatal day 7)
and staining increased through 28 days following partu-
rition but then decreased, with comparatively reduced cell
staining detected in 56-day-old adults [63]. The BDNF-IR
cell decrease detected in CA2 and CA3 in adulthood was
completely absent in colchicine-treated adults, which instead
showed an increase in BDNF-IR cells in these areas, possibly
reﬂecting increased accumulation of BDNF in the cell body
associated with inhibited axonal transport. BDNF-IR ﬁbers
were detected in the stratum lucidum layer of CA2 and CA3
and the polymorph layer of the DG also early on during
the intial 28-day postnatal period, and these BDNF-IR ﬁbers
actually continued to increase into adulthood [63].
BDNF serves a unique role among neurotrophins in de-
velopment, especially with regard to the cerebellum. An
examination of the cerebella of mice with a targeted BDNF
gene deletion (BNDF−/− mice) revealed that BDNF is essen-
tial for normal development and function of the cerebellar
cortex [13]. The study showed reduced Trk activation in
Purkinje cell bodies and dendrites in the mutant mice,
indicating a lack of redundancy among neurotrophins with
regard to BDNF in these cells. In BNDF−/− mice, there was
a dramatic increase in cell death among developing granule
cells, impaired development of the layers of the cerebellar
cortex, and irregular foliation in the middle and posterior
cerebellum; defects were apparent in the declival sulcus
(absent), the intercrural ﬁssure (absent), the prepyramidal
ﬁssure (nearly absent), and uvular sulcus (nearly absent)
[13].
BNDF is crucial to postnatal survival, as most BNDF−/−
mice die shortly after birth, but some do survive for a month
or more [64, 65]. Mice that lack BDNF demonstrate severe
deﬁciencies in PNS development, especially with regard to
aﬀerent neurons, but exhibit comparatively mild deﬁciencies
in CNS development [64, 66]. BNDF−/− mice show an4 International Journal of Peptides
abnormal gait with uncoordinated movements, and their
stance is substantially wider (distance between left and right
paws), despite their smaller size compared to wildtype mice
[13]. This evidence further implicates the importance of
BDNF not just to neuron development in the PNS but also
to cerebellar development and function.
Intraventricular BDNF application encourages neuroge-
nesis in several parts of the rat brain, such as striatum,
septum, thalamus, and hypothalamus [9], and infusion di-
rectly into the hippocampus increases the number of granule
cells in the DG [10]. Danzer and colleagues [12]t r a n s f e c t e d
hippocampal cells in culture with either BDNF or NGF;
DG granule cells exhibited considerable axonal and dendritic
branching following BDNF, but not NGF transfection. This
eﬀect was abolished with the application of a Trk receptor
tyrosine kinase inhibitor, demonstrating that BDNF and Trk
signaling promote neurogenesis both within and outside of
the context of development.
The involvement of p75NTR in reﬁning Trk receptor
selectivity may serve to modulate targeting of growing neu-
rons (see Figure 2), with neurotrophic factors acting as
markers [67]. Target tissues for growing PNS neurons (e.g.,
skeletal muscle) express neurotrophins [68], and BDNF is
released postsynaptically to inﬂuence CNS neurons in a
retrograde fashion [27, 69]. In a study of rat sympathetic
neurons that largely express NGF and TrkA receptors, BDNF
activated p75NTR-mediated apoptosis in conditions with
low available NGF [70]. For example, if a predominantly
NGF/TrkA-associated neuron were to grow to network with
a predominantly BDNF/TrkB-associated neuron, the grow-
ing neuron would quickly become apoptotic. Postsynaptic
BDNF release and activation of the presynaptic p75NTR
[55], coupled with the lack of NGF/TrkA signaling, would
reduce the survivability of the growing neuron. Thus
p75NTR serves a regulatory role with regard to Trk receptor
behavior and neuronal proliferation.
In summary, neurotrophins inﬂuence neuronal diﬀeren-
tiation [10] and are important to neuronal survival [16, 50–
52]. BDNF mRNA is present in relatively low levels early in
life and generally increases through to adulthood [59, 62],
especially in certain hippocampal neurons [63]. Studies of
micelackingBDNFdemonstratehowitisessentialforproper
PNS [64, 66] and cerebellar development [13].
4.SynapticPlasticity
BDNF is directly involved in the regulation of synaptic trans-
mission and activity-dependent synaptic plasticity by both
pre- and postsynaptic mechanisms [1, 23] (see Figure 3).
These mechanisms underlie the critical role of BDNF in
LTP [24–26, 29, 65]. In a study with cultured hippocampal
and cerebellar granule cells, Caldeira and colleagues [29]
demonstrated that BDNF increased the levels of NMDA
receptor subunits in the plasma membrane of hippocampal
cells. They recorded a correlated increase in intracellular
calcium concentration and described an increased calcium
entry through the additional NMDA receptors. Interest-
ingly, Hartmann and colleagues [69] stimulated cultured
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Figure 2: Neurotrophin signal involvement in targeting of growing
neurons. (a) Both TrkA and p75NTR are activated on the growing
neuron, survival and growth continues; (b) on the growing neuron,
p75NTR is activated by BDNF, but no TrkA activation takes place,
so apoptosis occurs. Adapted from [67].
hippocampal neurons presynaptically and detected a postsy-
naptic BDNF release, dependent upon calcium inﬂux, there-
by suggesting a BDNF-dependent positive feedback loop
between presynaptic and postsynaptic signaling in the gen-
eration of LTP.
Walz et al. [28] found that BDNF is essential for activity-
induced potentiation of presynaptic vesicle cycling in cul-
tured embryonic neocortical neurons of BDNF-knockout
mice. This phenomenon was dependent upon NMDA re-
ceptor activation, and was signiﬁcantly reduced in BDNF-
deﬁcientneurons,indicatingapossibleretrogrademessenger
or paracrine role for BDNF. In support of these ﬁndings,
previous work in BDNF knockout mice [65] showed a
pronounced impairment of vesicle docking in hippocampal
synapses while direct application of BDNF reversed the
deﬁcits. Estrogen promotes hippocampal plasticity, and in
ovariectomized rats, the loss of estrogen reduces cytoskeletal
reorganization in hippocampal dendritic spines and pro-
duces deﬁcits in LTP [11]. Kram´ ar and colleagues recently
demonstrated that application of BDNF to hippocampal sec-
tionsrestoredspineactinpolymerizationandLTPstabilityin
these rats [11].
Backpropagating (retrograde) action potentials modu-
late short- and long-term changes to synaptic activity [71]
and also serve to relieve the Mg2+ block on NMDA receptors
[72]. They are also suﬃcient to trigger a dendritic release of
BDNF [27]. The extent of backpropagation in a neuron is
dependent upon dendritic morphology, ion channel distri-
bution, and synaptic input [71]. Importantly, application of
an endoplasmic reticulum Ca2+-ATPase inhibitor stops thisInternational Journal of Peptides 5
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Figure 3: BDNF involvement in the induction of LTP and increased neuronal excitability. Aspects adapted from [1, 15].
dendritic BDNF release [27], suggesting a calcium-depend-
ent mechanism for retrograde release. These ﬁndings thus
revealseveralmechanismsforBDNF-mediatedpromotionof
LTP in the hippocampus [1].
BDNF is released in an activity-dependent manner,
as demonstrated in both hippocampal neurons [73]a n d
peripheral neurons [74]. While it may not be the only me-
diator of LTP, mice lacking BDNF demonstrated reduced
tetanus-induced LTP [30], a deﬁcit that disappeared with
the return of BDNF function [31]. Similarly, rats with a
r e d u c t i o ni nT r k Br e c e p t o r ss h o w e dr e d u c e dL T Pi n d u c -
tion [25]. As described above, BDNF works through both6 International Journal of Peptides
pre- and postsynaptic mechanisms to support LTP, and a
simultaneous block of pre- and postsynaptic PLC-γ activity,
but not either by itself, is required to reduce LTP in mouse
hippocampal cultures [26]. Interestingly, the involvement of
TrkBinLTPisnotcompletelydependentonBDNFsignaling;
NMDA receptors can activate TrkB by way of zinc inﬂux, and
adenosine 2A receptors can also inﬂuence TrkB [24].
In brief, BDNF is involved in traﬃcking NMDA receptor
subunits to the membrane, thereby increasing the potential
for calcium inﬂux [29]. Backpropagating action potentials
also inﬂuence calcium inﬂux by opening voltage-dependent
calcium channels [27]. A suﬃcient local buildup of calcium
causes postsynaptic BDNF release [69], which then leads
to an increase in presynaptic vesicle cycling [28]. These
mechanisms all serve to support LTP and synaptic plasticity.
5. Exercise
Exercise leads to substantial changes in BDNF and NMDA
receptor activity in the hippocampus, and these changes in
large part underlie the eﬀects of exercise on learning and
synaptic plasticity. In rats with free access to activity wheels
for one to six weeks, increases in hippocampal BDNF mRNA
[32, 33]a n dB D N Fp r o t e i n[ 34, 35] have been detected.
These increases in BDNF remain for some time after ces-
sation of exercise as well. Berchtold, Castello, and Cotman
demonstrated that hippocampal BDNF protein remained
elevatedfortwoweeksfollowingthreeweeksofaccesstocage
wheels (protein levels were 186% of controls at the end of
exercise, 137% one week followup, and 133% at two weeks)
[75].
Physical activity increases hippocampal BDNF expres-
sion after a relatively short amount of time, as voluntary
wheel running induced BDNF mRNA after only 6 hours of
running [37]. A substantial increase in BDNF mRNA in the
DGhasalsobeendescribedafter2weeks[39],3weeks[33],4
weeks [32], and 2 months of voluntary running [38]. BDNF
mRNA and protein induction due to exercise varies over the
life-span, however. Younger mice (2 months) exhibit a larger
increase compared to older mice (15 and 24 months) over
four weeks of running [34]. Forced treadmill running for 30
minutes per day for six weeks increased hippocampal BDNF
protein and BrdU positive proliferating cells in younger rats
(5 months), an eﬀect that was less robust but still signiﬁcant
in older rats (24 months) [76].
Exercise inﬂuences BDNF even under conditions of
homeostatic perturbations such as stress or dysfunction in
energy metabolism. In chronically stressed Sprague-Dawley
rats, access to cage wheels for six weeks only during dark
cycle(activeperiod)yieldedincreasedlevelsofBDNFprotein
in the striatum compared to sedentary rats [77]. The char-
acteristic lower levels of hippocampal BDNF protein and
dendritic spine density in type II diabetic mice (db/db)w e r e
signiﬁcantly enhanced with free access to cage wheels [78].
Under a condition of food deprivation every other day, six
weeks of wheel running still yielded signiﬁcantly increased
hippocampal BDNF protein compared to normally fed and
food-deprived sedentary Wistar rats, similar in magnitude to
the levels observed in normally fed exercising rats [79].
Running is associated with a robust activation of survival
pathways and vesicular proteins, eﬀects that are linked to
BDNF. Shen and colleagues [40] showed prolonged hip-
pocampal MAPK signaling following only a week of volun-
tary running. Chen and Russo-Neustadt [39] demonstrated
a signiﬁcant increase in hippocampal PI3K protein in rats
after two weeks of wheel running. In another study, Chen,
and Russo-Neustadt found a similar consequence of running
on Akt protein, an eﬀect dependent upon CREB signaling
[36]; in fact, the researchers showed that exercise-induced
increases in hippocampal BDNF protein and mRNA are also
CREB activation dependent, indicating the essential nature
of CREB signaling to exercise and BDNF-dependent cellular
survival eﬀects. These pathways are likely directly associated
with the neurogenesis detected in the DG of exercising rats
[80, 81].
Voluntaryexerciseselectivelyincreaseshippocampalsyn-
apsin I and synaptophysin mRNA [35, 82], a phenomenon
blocked by a recombinant human TrkB-IgG chimera, a high-
ly speciﬁc antagonist of BDNF [83]. Synapsin I tethers ves-
icles to the cytoskeleton [84] while synaptophysin may mod-
ulate vesicle recycling during high-intensity activity [85].
Indeed, this BDNF-mediated increase in synapsin following
exercise may in part explain how exercise enhances LTP,
along with the other mechanisms for BDNF-facilitated LTP
described above. Running rats show a lower threshold for
LTP induction in the DG [32]. Voluntary running also
yielded better performance on the Morris water maze test
[81], an LTP-associated eﬀect abolished with the selective
blocking of BDNF [86]. Importantly, Farmer and colleagues
[32] also identiﬁed an increase in NMDA receptor subunit
NR2B mRNA in the DG following activity wheel running,
which may represent yet another mechanism explaining how
exercise promotes LTP and learning and memory.
6. Excitotoxicity
A complicated relationship exists between BDNF and
epileptogenic hyperexcitability, but this relationship may be
fundamentally characterized as a positive feedback loop. In
general, enhanced BDNF signaling is associated with in-
creased excitability, presumably through increased synaptic
plasticity. As described above, increased neural activity tends
to promote BDNF functions. For example, mRNA and
protein levels for BDNF are increased in the hippocampus
afterseizure[66,87],andBDNFknockoutmicedemonstrate
reduced seizure behavior in response to kindling [88]. In
transgenic mice with an overexpression of the truncated
TrkB receptor, the reduced BDNF signaling led to reduced
seizure activity after systemic kainic acid administration
[58]. Koyama et al. [89] demonstrated development of hy-
perexcitable circuits due to abnormal mossy ﬁber sprouting,
in part caused by activity-induced BDNF release and Trk
receptoractivity.Thissproutingdidnotoccurinthepresence
of a Trk receptor tyrosine kinase inhibitor or anti-BDNFInternational Journal of Peptides 7
antibody. Such abnormal remodeling is, in part, responsible
for dentate hyperexcitability [89, 90].
Glutamatergic excitotoxicity, thought to result from
excessive calcium inﬂux via NMDA receptors [91], is a major
contributor to neuronal damage associated with anoxia
[92], ischemia [93], and seizure [94]. In cultured cerebellar
granule cells, high glutamate concentrations cause immedi-
ate necrosis [95]. Following withdrawal to normal medium,
surviving cells undergo apoptosis over time. In rat hip-
pocampal cell cultures, a high concentration of glutamate
caused mainly necrosis while a lower concentration of glu-
tamate led almost exclusively to delayed apoptosis [95].
Glazner and Mattzon [96] evaluated the eﬀect of BDNF
application on NMDA receptor subunits, and found that
NR1 and NR2A protein levels are increased whereas NR2B
levels are decreased; associated eﬀects included increased
calcium response to NMDA activation, increased necrosis
(cell swelling), and decreased apoptosis (cell shrinkage and
chromatinfragmentation).BDNF-mediatedenhancementof
NMDA receptor functions are consistent with the eﬀects of
exercise on increasing NMDA receptor expression described
above [32], further supporting the role of BDNF in exercise-
enhanced synaptic plasticity. These results further illustrate
how BDNF overexpression may lead to hyperexcitable cir-
cuitry through multiple mechanisms.
BDNF thus encourages neurogenesis [9, 10], axonal,
and dendritic sprouting [89], and NMDA receptor-mediated
transmission [96] in a Trk-B-dependent manner [12], which
are generally considered to be beneﬁcial eﬀects on neuronal
function. However, these same mechanisms may lead to
hyperexcitable circuits in the DG [89, 90, 97], which may
eventually lead to spreading excitotoxicity. This condition
can therefore become a self-sustaining cycle of sprouting
and hyperexcitability, fueled in part by activity-dependent
BDNFrelease[69,73,74].Inakainicacidmodeloftemporal
lobe epilepsy utilizing transgenic mice, increased TrkB sig-
naling facilitated signiﬁcantly shorter time to epileptogenesis
and more severe epileptiform electroencephalogram activity
comparedtowild-typemice,andepileptogenesiswasdelayed
in reduced TrkB (truncated form) mice [98].
Based on this evidence for a prolonged state of hyperex-
citability coupled with a shorter facilitation resulting from
enhanced expression of BDNF or TrkB signaling in the hip-
pocampus, it follows that exercise-induced plasticity could
leave the brain more vulnerable to epileptic seizures and ex-
citotoxicity. Some experimental evidence supports this
hypothesis. Microinjections of kainic acid into the hip-
pocampi of anaesthetized rats produce more damage in
subjects that were provided with running wheels for several
weeks compared to sedentary controls [99]. This enhanced
excitotoxicity in exercising rats was interpreted by the inves-
tigatorsasaconsequenceofexercise-inducedupregulationof
hippocampal BDNF expression.
On the other hand, a large body of evidence from both
clinical studies in humans and basic research in animal
models reveals that physical exercise produces a wide range
of neuroprotective eﬀects [100–103]. For example, exercise
in humans decreases risk of neurological disease and stroke,
and it may improve recovery after brain trauma [101]. The
brain damage caused by experimental infarct is diminished
in exercising rats compared to sedentary controls [103].
Exercise also protects against oxidative stress [101], and the
neurotoxic eﬀects of 6-OHDA [104, 105]a n dM P T P[ 106].
Since neural hyperexcitability is a mechanism for the injury
and death that occurs in all of these neurological insults
and/or disorders [107, 108], determining how exercise pro-
tects against excitotoxicity should have broad implica-
tions for understanding its beneﬁcial eﬀects on the brain.
Nonetheless, these conditions are only indirectly linked to
excitotoxicity,andamoredirectexaminationoftheinﬂuence
of exercise on hyperexcitability is required to understand the
mechanisms for its neuroprotective eﬀects.
In contrast to the ﬁndings of Ramsden and colleagues
[99] described above, in which exercise led to increased
excitotoxicty when kainic acid was injected into the hip-
pocampus of anaesthetized rats, some evidence suggests that
exercise may protect against hyperexcitability. Experiments
speciﬁcally designed to this hypothesis have revealed that
exercise protects against kainic acid-induced seizures when
studied in awake, freely behaving rats. Reiss et al. [109]r e -
ported that three weeks of voluntary exercise decreases the
eﬀects of kainic acid on seizure behaviors and hippocampal
c-fos expression. Further supporting the hypothesis that
exercise diminishes hyperexcitability are similar reports of
exercise protecting against experimentally induced seizures
using other convulsant manipulations [110, 111]. Exercise
also diminishes the excitotoxic eﬀects of systemic domoic
acid in mice [112] and reduces the learning deﬁcits caused
by systemic kainic acid administration in rats [100].
Taken together, the conﬂicting ﬁndings of exercise ef-
fects on hyperexcitability and excitotoxicity suggest that an
exercise-induced compensatory mechanism may counter
the hyperexcitable state associated with upregulation of
BDNF.Importantly,thiscompensatorymechanismmayonly
function in awake, freely behaving subjects. In the report
by Ramsden and colleagues, the exercise-associated increase
in neurotoxicity caused by kainic acid injected directly into
the hippocampi was observed in anesthetized rats [99]. A
complex, polysynaptic protective mechanism may have been
eliminatedbytheanaesthesia.Ifsuchamechanismdepended
on extrahippocampal circuitry, then it is reasonable to as-
sume that it may not engage in an anaesthetized state.
Though it is likely that a variety of mechanisms exist to
counter the hyperexcitable state in the hippocampus caused
byBDNF,elucidationofsuchamechanismrelatedtoexercise
should be based on speciﬁc criteria. This mechanism should
involvesomeneuralfactorthat(1)isupregulatedbyexercise,
(2)diminishesneuralhyperexcitabilityacutely,and(3)exerts
latent neuroprotective eﬀects. Research from this laboratory
suggests that hippocampal aﬀerents originating from the
noradrenergic locus coeruleus may be a critical component
of this mechanism. More speciﬁcally, experimental evidence
points to the neuropeptide galanin as a critical factor in
dampening hippocampal excitability.
Galanin is a 29-30 amino acid neurotransmitter and pu-
tative trophic factor that regulates neural activity in several
brain structures, most notably the hypothalamus and hip-
pocampus. Galanin coexists extensively with norepinephrine8 International Journal of Peptides
in locus coeruleus neurons [113]. Retrograde tracing/double
labeling experiments reveal that the hippocampus receives
galaninergic innervation via projections from the locus
coeruleus [114]. At least three G-protein coupled galanin re-
ceptor subtypes have been conﬁrmed, designated GAL R1-3.
Galaninergic transmission is predominantly inhibitory, pro-
ducing hyperpolarization through increased K+ or decreased
Ca2+ conductance [115].
Several lines of evidence reveal that galanin functions
as an endogenous neuroprotective factor for hippocampal
neurons [116–118]. This neuroprotection appears to be me-
diated primarily through the regulation of hippocampal ex-
citability. Infusion of galanin into the hippocampus inhibits
seizures provoked by a variety of methods, and the galanin
receptor antagonists M-35- and M-40 block the antiseizure
eﬀects of galanin [117]. Transgenic galanin knock-out mice
show increased susceptibility to kainic acid-induced seizures
whereas transgenic mice overexpressing galanin display a
resistance to these seizures [119]. Hippocampal electro-
physiological activity is similarly exaggerated in the galanin
knockouts and decreased in galanin overexpressers [119]. In
vitro studies in hippocampal cultures from transgenic mice
have conﬁrmed that endogenous galanin diminishes excito-
toxicity and apoptosis [116].
Previous work from this laboratory has demonstrated
that either three weeks of voluntary wheel running or tread-
mill training increases galanin gene expression in locus
coeruleus neurons in rats [120–123]. No exercise-induced
changes in neuropeptide-Y or tyrosine hydroxylase were ob-
served in these studies, suggesting that locus coeruleus neu-
rons respond to exercise by speciﬁcally upregulating galanin.
The critical role of galanin in mediating the protective ef-
fects of exercise against convulsant-induced seizures was
demonstrated by the administration of the galanin receptor
antagonist M-40, which largely blocked the neuroprotection
as measured by behavioral seizure severity [109]. Galanin
receptor blockade thus decreased the anticonvulsant eﬀects
of exercise. These results suggest that exercise-induced up-
regulation of galanin mediates the enhanced inhibitory tone
that may counteract BNDF-mediated hyperexcitability.
7. Summary and Conclusion
To conclude, BDNF receptor activity encourages neurogene-
sis[9,10],suppressesapoptosis[16],andmodulatessynaptic
activity via a variety of signaling cascades [45, 48, 50]. These
eﬀects are beneﬁcial with regard to development [1, 8]a n d
synaptic plasticity [25, 26, 29, 65], but can be harmful in
conditions sensitive to hyperexcitability [58].
Dendritic BDNF release is activity-dependent, based on
calcium inﬂux [27, 69]. This release causes an increase in
presynaptic vesicle cycling [28], which further stimulates
synaptic activity. The BDNF-induced increase in NMDA
receptor subunits [29] creates more opportunity for calcium
inﬂux, supporting additional BDNF release. The increased
TrkB signaling boosts IP3 activity and intracellular calcium
release, contributing to the enhancement of the cycle even
further.Theseprocessesfeedoﬀofoneanothertooverwhelm
Neurite outgrowth/
neurogenesis
Vesicle cycling Glutamate
release
BDNF release
NMDAR subunit
cycling
inﬂux Ca2+
Figure 4: BDNF involvement in the development of hyperexcitable
circuits in the hippocampus; although this cycle serves to support
LTP and plasticity, it can become overwhelmed under certain exci-
totoxic conditions and serve to further promote those conditions.
any modulatory eﬀects of truncated TrkB receptors (which
bind BDNF but lack tyrosine kinase function [57]) or
p75NTR, the latter of which will act more to reﬁne the ac-
tions of the increased available BDNF to yet further poten-
tiate the cycle. Since BDNF encourages neurogenesis [9, 10]
and neurite outgrowth [12], the eﬀects of these processes are
further compounded with the establishment of additional
excitatory synapses (see Figure 4).
ThushyperexcitablecircuitsintheDGcandevelopdueto
excessive BDNF and NMDA receptor activity [89, 90], activ-
itythatmaintainsaself-supportingcycleofneurotransmitter
release in the hippocampus that can be overwhelmed to
promote excitotoxic vulnerability. Considering the mal-
adaptive nature of this condition, selection for hip-
pocampal circuitry that regulates this hyperexcitability
would provide clear evolutionary beneﬁts. Furthermore, en-
vironmental stimuli that promote hippocampal BDNF ex-
pression, such as exercise, would be expected to engage
this compensatory mechanism. Evidence suggests that a
circuit including galaninergic projections from the LC to
the hippocampus provides this function [116, 118, 120, 121,
123].
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